A new study has found that an experimental drug may delay the onset of Alzheimer’s-related dementia in people who are almost ...

Unlike expensive positron emission tomography (PET) scans or invasive lumbar punctures, the new blood test measures the ratio of two proteins, pTau217 and ß-Amyloid 1-42, which are implicated in ...

Cognitive decline is a growing concern in aging societies, often impacting memory, attention, and decision-making. For ...

Neuroscientists have taken a major step toward detecting Alzheimer’s disease in its earliest stages—long before memory loss ...

In a significant breakthrough in the fight against Alzheimer’s and age-related cognitive decline, a new study has revealed ...

Understand the 6 stages of Alzheimer’s disease, from early signs to final care, and how families can support loved ones ...

A surprising new study has uncovered over 200 misfolded proteins in the brains of aging rats with cognitive decline, beyond ...

For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

Alzheimer’s may be driven by more than just plaques—scientists have discovered 200+ hidden proteins that could be quietly ...

Alzheimer's disease progression linked to microglia fat metabolism, potential new treatment target identified in recent study ...

For decades, the story of Alzheimer’s research has been dominated by a battle between amyloid-beta and tau amyloids, both of ...